Your browser doesn't support javascript.
loading
SARS-CoV-2 outbreak in Iran: The dynamics of the epidemic and evidence on two independent introductions.
Fattahi, Zohreh; Mohseni, Marzieh; Jalalvand, Khadijeh; Aghakhani Moghadam, Fatemeh; Ghaziasadi, Azam; Keshavarzi, Fatemeh; Yavarian, Jila; Jafarpour, Ali; Mortazavi, Seyedeh Elham; Ghodratpour, Fatemeh; Behravan, Hanieh; Khazeni, Mohammad; Momeni, Seyed Amir; Jahanzad, Issa; Moradi, Abdolvahab; Tabarraei, Alijan; Azimi, Sadegh Ali; Kord, Ebrahim; Hashemi-Shahri, Seyed Mohammad; Azaran, Azarakhsh; Yousefi, Farid; Mokhames, Zakiye; Soleimani, Alireza; Ghafari, Shokouh; Ziaee, Masood; Habibzadeh, Shahram; Jeddi, Farhad; Hadadi, Azar; Abdollahi, Alireza; Kaydani, Gholam Abbas; Soltani, Saber; Mokhtari-Azad, Talat; Najafipour, Reza; Malekzadeh, Reza; Kahrizi, Kimia; Jazayeri, Seyed Mohammad; Najmabadi, Hossein.
Affiliation
  • Fattahi Z; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Mohseni M; Kariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran.
  • Jalalvand K; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Aghakhani Moghadam F; Kariminejad-Najmabadi Pathology & Genetics Center, Tehran, Iran.
  • Ghaziasadi A; Student Research Committee, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Keshavarzi F; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Yavarian J; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Jafarpour A; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Mortazavi SE; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghodratpour F; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Behravan H; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Khazeni M; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Momeni SA; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
  • Jahanzad I; Department of Microbiology, Faculty of Biology, College of Science, University of Science & Research, Tehran, Iran.
  • Moradi A; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Tabarraei A; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Azimi SA; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Kord E; Booali Laboratory, Qom, Iran.
  • Hashemi-Shahri SM; Booali Laboratory, Qom, Iran.
  • Azaran A; Pars Hospital Laboratory, Rasht, Iran.
  • Yousefi F; Infectious Diseases Research Center, Golestan University of Medical Sciences, Golestan, Iran.
  • Mokhames Z; Infectious Diseases Research Center, Golestan University of Medical Sciences, Golestan, Iran.
  • Soleimani A; Infectious Diseases Research Center, Golestan University of Medical Sciences, Golestan, Iran.
  • Ghafari S; Infectious Disease and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Ziaee M; Infectious Disease and Tropical Medicine Research Center, Resistant Tuberculosis Institute, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Habibzadeh S; Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Jeddi F; Department of Virology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Hadadi A; Department of Molecular Diagnostic, Emam Ali Educational and Therapeutic Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Abdollahi A; Department of Molecular Diagnostic, Emam Ali Educational and Therapeutic Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Kaydani GA; Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  • Soltani S; Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
  • Mokhtari-Azad T; Department of Infectious Disease, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Najafipour R; Department of Infectious Disease, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Malekzadeh R; Department of Infectious Disease, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Kahrizi K; Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Jazayeri SM; Department of Laboratory Sciences, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Najmabadi H; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Transbound Emerg Dis ; 69(3): 1375-1386, 2022 May.
Article de En | MEDLINE | ID: mdl-33835709
ABSTRACT
The SARS-CoV-2 virus has been rapidly spreading globally since December 2019, triggering a pandemic, soon after its emergence. While Iran was among the first countries confronted with rapid spread of virus in February 2020, no real-time SARS-CoV-2 whole-genome tracking in early phase of outbreak was performed in the country. To address this issue, we provided 50 whole-genome sequences of viral isolates ascertained from different geographical locations in Iran during March-July 2020. The corresponding analysis on origins, transmission dynamics and genetic diversity of SARS-CoV-2 virus, represented at least two introductions of the virus into the country, constructing two major clusters defined as B.4 and B.1*. The first entry of the virus might have occurred around very late 2019/early 2020, as suggested by the time to the most recent common ancestor, followed by a rapid community transmission that led to dominancy of B.4 lineage in early epidemic till the end of June. Gradually, reduction in dominancy of B.4 occurred possibly as a result of other entries of the virus, followed by surge of B.1* lineages, as of mid-May. Remarkably, variation tracking of the virus indicated the increase in frequency of D614G mutation, along with B.1* lineages, which showed continuity till October 2020. The increase in frequency of D614G mutation and B.1* lineages from mid-May onwards predicts a rapid viral transmission that may push the country into a critical health situation followed by a considerable change in composition of viral lineages circulating in the country.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Animals Pays/Région comme sujet: Asia Langue: En Journal: Transbound Emerg Dis Sujet du journal: MEDICINA VETERINARIA Année: 2022 Type de document: Article Pays d'affiliation: Iran

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Animals Pays/Région comme sujet: Asia Langue: En Journal: Transbound Emerg Dis Sujet du journal: MEDICINA VETERINARIA Année: 2022 Type de document: Article Pays d'affiliation: Iran